Single and Multiple Ascending Dose Study in Healthy Participants and Participants With an Autoimmune Disease

NCT06488209 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

69

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers
Autoimmune Disease

Interventions

DRUG: LAD191
OTHER: Placebo

Sponsor

Almirall, S.A.